I-ADD Study: Assessment of Efficacy and Safety Profile of Irbesartan/Amlodipine Fixed-Dose Combination Therapy Compared With Irbesartan Monotherapy in Hypertensive Patients Uncontrolled With Irbesartan 150 mg Monotherapy: A Multicenter, Phase III, Prospective, Randomized, Open-Label With Blinded–End Point Evaluation Study
- Resource Type
- Article
- Source
- In
Clinical Therapeutics August 2012 34(8):1720-1734 - Subject
- Language
- ISSN
- 0149-2918